TCL Archive FDA Approves New Indication For Anticoagulant Frangmin By Cancer History Project May 25, 2007
TCL Archive After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency. By Cancer History Project May 18, 2007
TCL Archive Amgen Claimed QOL Benefit Despite FDA Label Change. By Cancer History Project May 18, 2007
TCL Archive “Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising. By Cancer History Project May 18, 2007
TCL Archive FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising. By Cancer History Project May 18, 2007
TCL Archive CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say. By Cancer History Project May 18, 2007
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project